Experimental Research of the Prevention and Treatment of H22 Liver Cancer Treated with Nidus Vespae Extract and Its Mechanism in Mice

Wang Zhao-hui

Abstract:Objective To observe the tumor inhibition effect of nidus vespae extract on tumor-bearing H22 mice and the impacts on the life span of mice with ascites tumor and explore the mechanism on anti-tumor.Methods 80 mice were randomized into 2 batches,40 mice in each one.Separately,H22 liver cancer cells were inoculated in the right axilla and the abdominal cavity to prepare solid tumor and ascites tumor models.Four groups were randomized in each batch,named a salty water control group,a 5-FU group,a high-dose nidus vespae extract group and a low-dose nidus vespae extract group,10 mice in each one.In the solid tumor model group,the medication was given continuously for 14 days.The mice were sacrificed on the next day.The tumor was collected and weighted and the tumor inhibition rate was calculated.The immunohistochemical technology was adopted to detect the expressions of Histone H1 and Cyclin B1.In the ascites tumor model group,after continuous medication for 14 days,the survival days were recorded for the mice in each group.The life extension rate was calculated.Results In the high-dose nidus vespae extract group,the growth inhibition rate of liver cancer cell was 38.06%,the expression of Histone H1 was increased and that of Cyclin B1 was decreased,indicating the significant difference as compared with the control group(P0.01).Additionally,the life span of the mice with ascites tumor was extended apparently.Conclusion Nidus vespae extract acts on the inhibition of liver cancer cell and its mechanism is probably related to the regulation of Histone H1 and Cyclin B1.

Medicine